In the mid-2000s, the National Cancer Institute (NCI) in the US brought together a group of experts to try to overcome an issue that had arisen in the reporting of results from breast cancer clinical trials.
Dec 7, 2021
0
7
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the Journal of the American College ...
Nov 4, 2022
0
21
Older women with early-stage, invasive breast cancer had better survival rates than what was estimated by a popular online tool for predicting survival, according to researchers at the Duke Cancer Institute.
Dec 9, 2015
1
1
Four years after being treated for breast cancer, a quarter of survivors say they are worse off financially, at least partly because of their treatment, according to a new study led by University of Michigan Comprehensive ...
Mar 25, 2014
0
0
(HealthDay)—Personalized dietary recommendations based on molecular characteristics of primary tumor tissue may be an effective strategy for breast cancer survivors, according to research published in the July issue of ...
Jun 20, 2014
0
0
Hormonal treatment for breast cancer causes menopause in over 80% of women in the first year of therapy, but now new research, published in the peer-reviewed journal Climacteric, has found that how these women are diagnosed ...
Aug 13, 2013
0
0
Researchers from The University of Western Australia believe General Practitioners can play an important role in ensuring women persist with cancer treatment.
Jul 27, 2017
0
5
Newly published research from a National Cancer Institute-funded randomized trial shows that women who were provided with skills to manage stress early in their breast cancer treatment show greater length of survival and ...
Dec 1, 2015
0
2
(HealthDay)—Accelerated partial breast irradiation (APBI) yields five-year clinical outcomes and patterns of failure similar to those achieved with whole breast irradiation (WBI), with excellent three-year survival for ...
Aug 24, 2012
0
0
Women treated for breast cancer after menopause with aromatase inhibitors have very high levels of sexual difficulties, including low interest, insufficient lubrication, and pain with intercourse. It is an important and underestimated ...
Sep 24, 2012
0
0
